Taking all this into consideration along with the fact that over 2000 mutations have been identified in the cftr gene with an unknown number belonging to class 2, the need to expand the arsenal of CFTR corrector therapies to develop complete clinical coverage of class 2 CFTR mutation-derived CF becomes clear. Here, CFTR is linked to cystic fibrosis.